摘要
2014年国内中药材市场整体走势高开低走,与年初预估吻合。期间虽然经过两次震荡反弹,部分野生品种、养生保健品种量价齐升,为低迷的行情注入活力,但由于家种品种过量及旧库存滞胀等因素,综合200指数较2013年依然下降了2.13%。以综合200指数运行情况,结合市场需求增长、产销对接加快,以及资源、劳力成本等因素分析认为,2015年市场行情再度下跌的空间十分有限,综合200指数将会形成新一轮的低位整理态势,在2015年下半年有望企稳回升。
In this paper,the circumstances of Chinese materia medica market in 2014 are sorted and analyzedIn 2014,the market began high ended low as estimated at the beginning of this yearAlthough the market rebounded twice,the price and quantity of some wild species and health care species went higher,the composite 200 index still fell 213% comparing with 2013 due to excessive domestic species and overstocked previous speciesConsidering market demand,accelerated marketing docking,resources and labor costs,the price falling weill be limited in 2015As the analysis indicates,the composite 200 index will form a new round of low order readjustmentsFurthermore,in the second half year of 2015,the index will have the chance to rebound
出处
《中国现代中药》
CAS
2015年第1期64-68,共5页
Modern Chinese Medicine
关键词
中药材
市场
分析
展望
Chinese materia medica
market
analysis
prospect